This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

OncoMed Pharmaceuticals Inc (OMED)

NASDAQ: Health Care

Company Cash Flow
Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) -26.07M -22.24M -15.03M
Operating Gains/Losses 0.00 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00
(Increase) Decrease In Receivables 4.00M -4.02M 9.00M
(Increase) Decrease in Inventories 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00
(Decrease) Increase In Payables 4.86M -3.18M 1.32M
(Decrease) Increase In Other Current Liabilities 18.71M 0.00 0.00
(Increase) Decrease In Other Working Capital 139.92M -5.48M -9.14M
Other Non-Cash Items 2.03M 824.00K 857.00K
Net Cash From Continuing Operations 144.54M -33.34M -11.29M
Net Cash From Discontinued Operations 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 144.54M -33.34M -11.29M
Sale of Property, Plant & Equipment 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 75.30M 112.67M 113.53M
Purchases of Property, Plant & Equipment -557.00K -714.00K -2.25M
Acquisitions 0.00 0.00 0.00
Purchases of Short-Term Investments -132.54M -73.94M -103.88M
Other Cash from Investing Activities 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -57.79M 38.01M 7.41M
Issuance of Debt 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 250.00K 156.00K 22.00K
Repayment of Long-Term Debt 0.00 -346.00K -703.00K
Repurchase of Capital Stock 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00
Other Financing Charges, Net 105.67M 0.00 0.00
Net Cash From Financing Activities 105.92M -190.00K -681.00K
Effect of Exchange Rate Changes 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents 192.67M 4.48M -4.56M
OMED News

OMED OncoMed Pharmaceuticals Inc

Analysts Ratings for OMED

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 5 4 4
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET OMED ANALYST REPORT

Brokerage Partners

OMED Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs